Intravenous immunoglobulin in systemic capillary leak syndrome: A case report and review of literature

Expert Review of Clinical Immunology

Volumn 10, Issue 3, 2014, Pages 349-352

  Marra, Alessandro M ^a   Gigante, Antonietta ^a   Rosato, Edoardo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

intravenous immunoglobulin; systemic capillary leak syndrome; therapy

Indexed keywords

CAPILLARY LEAK SYNDROME; CAPILLARY PERMEABILITY; CLINICAL TRIALS AS TOPIC; DISEASE-FREE SURVIVAL; EDEMA; EUROPE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; MIDDLE AGED; RECURRENCE; SHOCK; TERBUTALINE; THEOPHYLLINE;

EID: 84894318801     PISSN: 1744666X     EISSN: 17448409     Source Type: Journal    
DOI: 10.1586/1744666X.2014.882771     Document Type: Article

References (11)

1. Druey KM, Greipp PR. Narrative review: the systemic capillary leak syndrome. Ann Intern Med 2010;153(2):90-8
2. Gousseff M, Arnaud L, Lambert M, et al. The systemic capillary leak syndrome: a case series of 28 patients from a European registry. Ann Intern Med 2011;154(7):464-71
3. Dhir V, Arya V, Malav IC, et al. Idiopathic systemic capillary leak syndrome (SCLS): case report and systematic review of cases reported in the last 16 years. Intern Med 2007;46(12):899-904
4. Tahirkheli NK, Greipp PR. Treatment of the systemic capillary leak syndrome with terbutaline and theophylline. A case series. Ann Intern Med 1999;130(11):905-9
5. Gousseff M, Amoura Z. Idiopathic capillary leak syndrome. Rev Med Interne 2009; 30(9):754-68
6. Michiels JJ, Berneman Z, Gadisseur A, et al. Immune-mediated etiology of acquired von Willebrand syndrome in systemic lupus erythematosus and in benign monoclonal gammopathy: therapeutic implications. Semin Thromb Hemost 2006;32(6):577-88
7. Lambert M, Launay D, Hachulla E, et al. High-dose intravenous immunoglobulins dramatically reverse systemic capillary leak syndrome. Crit Care Med 2008;36(7): 2184-7
8. Bayary J, Dasgupta S, Misra N, et al. Intravenous immunoglobulin in autoimmune disorders: an insight into the immunoregulatory mechanisms. Int Immunopharmacol 2006;6(4):528-34
9. Xie Z, Ghosh CC, Patel R, et al. Vascular endothelial hyperpermeability induces the clinical symptoms of Clarkson disease (the systemic capillary leak syndrome). Blood 2012;119(18):4321-32
10. Orbach H, Tishler M, Shoenfeld Y. Intravenous immunoglobulin and the kidney-a two-edged sword. Semin Arthritis Rheum 2004;34(3):593-601
11. Daniel GW, Menis M, Sridhar G, et al. Immune globulins and thrombotic adverse events as recorded in a large administrative database in 2008 through 2010. Transfusion 2012;52(10):2113-21